This research group is a collective of highly accomplished professionals united by their shared commitment to advancing nanotechnology, drug delivery systems, and biomedical applications. The team’s expertise spans various fields including nanobiotechnology, pharmaceutics, chemical biology, and material sciences, with a primary focus on innovative therapeutic solutions. Key members of the group include Dr. Walhan Alshaer, a distinguished researcher at the University of Jordan, specializing in ligand-guided nanomedicines for targeted drug delivery, and Prof. Alaaldin M. Alkilany, a leading expert in nanomaterials for drug delivery at Qatar University, recognized as one of the top 2% of scientists globally. Additionally, Dr. Ahmad Telfah, with his background in physical chemistry and nanotechnology, contributes through his expertise in computational modeling and high-resolution analytical techniques. Prof. Sharif Abdelghany, a Professor in the Department of Pharmaceutics and Pharmaceutical Technology at the University of Jordan since 2012, brings significant expertise in drug delivery and biomaterials. He has published extensively on microneedles and nanoparticles for drug delivery, focusing on safe, pain-free delivery systems for diseases like cancer, diabetes, and infectious diseases. Dr. Khaled Khraisat, the Founder and CEO of JAIP (Academia Industry Platform Co.Ltd), has 27 years of experience in business development within the life sciences industry. He brings a wealth of knowledge in strategic planning, business modeling, and industrial project management, along with extensive experience in scaling up businesses in pharmaceutical, cosmetic, and food industries....